E3 PreliminaryPreliminaryPEM ✓Machine draft
The development of an instrument to assess post-exertional malaise in patients with myalgic encephalomyelitis and chronic fatigue syndrome.
Jason, Leonard A, Holtzman, Carly S, Sunnquist, Madison et al. · Journal of health psychology · 2021 · DOI
Quick Summary
This study created a new questionnaire called the DePaul Post-Exertional Malaise Questionnaire to measure post-exertional malaise (PEM)—the worsening of symptoms that happens after physical or mental activity in ME/CFS patients. Researchers worked with hundreds of patients to develop questions that accurately capture what PEM feels like. Early testing showed the questionnaire works well and connects meaningfully with how much physical activity patients can do.
Why It Matters
Post-exertional malaise is a defining feature of ME/CFS mentioned in virtually all diagnostic criteria, yet researchers and clinicians previously lacked a standardized, comprehensive tool to measure it. This questionnaire fills that critical gap, enabling better assessment of PEM in clinical practice and research studies. Having a validated PEM measurement tool could improve diagnosis, track disease progression, and help evaluate potential treatments.
Observed Findings
- A comprehensive questionnaire assessing post-exertional malaise was successfully developed based on input from hundreds of ME/CFS patients.
- Significant correlations were found between different domains of the DePaul PEMQ and physical functioning measures.
- The questionnaire demonstrated predictable relationships across multiple symptom domains of PEM.
Inferred Conclusions
- The DePaul Post-Exertional Malaise Questionnaire captures clinically relevant dimensions of PEM that relate meaningfully to physical functioning.
- A patient-informed, multi-domain approach to measuring PEM is more comprehensive than previous ad-hoc assessment methods.
- This instrument has potential for use in both clinical assessment and research applications.
Remaining Questions
- What are the full psychometric properties (reliability, sensitivity, specificity) in larger, independent validation cohorts?
- How does the DePaul PEMQ compare to other existing PEM measurement approaches or single-item severity scales?
- Can the questionnaire reliably track changes in PEM severity over time in clinical trials or during natural disease progression?
- Does the questionnaire perform equally well across different ME/CFS disease severity levels and patient subgroups?
What This Study Does Not Prove
This study develops and preliminarily validates an assessment tool; it does not establish new biological mechanisms of PEM or prove what causes post-exertional malaise. The preliminary validation phase does not constitute full psychometric validation, which would require larger, independent samples. The study cannot determine whether the questionnaire is superior to existing informal assessment methods used in clinical practice.
Tags
EXPLORATORYPEM DEFINED
Metadata
- DOI
- 10.1177/1359105318805819
- PMID
- 30354489
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026